The director of research and co-director at UR Medicine’s Wilmot Cancer Institute has received a $6.3 million award from the National Cancer Institute.
Hartmut Land, the Robert and Dorothy Markin Professor of Biomedical Genetics at the University of Rochester, received the newly established award that supports exceptional scientists with seven years of uninterrupted funding.
The NCI Outstanding Investigator Award is in its inaugural year. It was designed to reward productive and influential researchers by giving them the freedom to pursue long-term goals without having to re-submit grants each cycle.
Land will continue to test a bold hypothesis that has been the cornerstone of his work for 30 years—that different cancers have many shared features, and understanding the common characteristics of cancer might unlock the next generation of targeted treatments, officials said.
“I feel very grateful and a bit humbled,” said Land, in a statement. “It’s a wonderful affirmation of our focus on the common core of cancers and the work of our research team.”
The new NCI funding is known as an R35 award; 60 other scientists in the United States will receive R35 grants on a rolling basis this year, with Land among the first. He expects to receive $6.3 million, broken into annual payments, until 2022.
(c) 2015 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or email email@example.com.